-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
Clinical trial end points relevant to patients and society for rare cancers
Shelize Khakoo, Alexandros Georgiou & Ian Chau
Clinical Trail Methodology: Clinical Investigation
-
The adaptive trial opportunity for biotechs and smaller pharmaceutical companies
Tom Parke
Editorial: Clinical Investigation
-
The adaptive trial opportunity for biotechs and smaller pharmaceutical companies
Tom Parke
Editorial: Clinical Investigation
-
The adaptive trial opportunity for biotechs and smaller pharmaceutical companies
Tom Parke
Editorial: Clinical Investigation
-
The adaptive trial opportunity for biotechs and smaller pharmaceutical companies
Tom Parke
Editorial: Clinical Investigation
-
The adaptive trial opportunity for biotechs and smaller pharmaceutical companies
Tom Parke
Editorial: Clinical Investigation
-
The adaptive trial opportunity for biotechs and smaller pharmaceutical companies
Tom Parke
Editorial: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation
-
Cancer stem cells as a therapeutic target of the future
Jiri Hatina
Editorial: Clinical Investigation